You are here:
Refine Your Search
Search Again
Search Within
More Results
Records 1 to
23
of 23 records from author John Lipscomb
2022
Pfohl, M., E. Silvestri, J. Lipscomb, E. Snyder, AND S. Willison. Evaluating risk, exposure, and detection capabilities for chemical threats in water. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH - PART A: CURRENT ISSUES. Taylor & Francis, Inc., Philadelphia, PA, 85(15):622-647, (2022). https://doi.org/10.1080/15287394.2022.2064949
2020
Kenyon, E., C. Eklund, R. Pegram, AND J. Lipscomb. Comparison of In Vivo Derived and Scaled In Vitro Metabolic Rate Constants for Several Volatile Organic Compounds (VOCs). TOXICOLOGY IN VITRO. Elsevier Science Ltd, New York, NY, 69:105002, (2020). https://doi.org/10.1016/j.tiv.2020.105002
2019
Kenyon, E., J. Lipscomb, R. Pegram, BJ George, AND R. Hines. THE IMPACT OF SCALING FACTOR VARIABILITY ON RISK-RELEVANT PHARMACOKINETIC OUTCOMES IN CHILDREN: A CASE STUDY USING BROMODICHLOROMETHANE (BDCM). TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 167(2):347-359, (2019). https://doi.org/10.1093/toxsci/kfy236
2018
Lipscomb, J. Application of Quantitative Dose-Response Data in Risk Assessment and the Incorporation of High-Throughput Data. Chapter 48, Handbook of Developmental Neurotoxicology. Elsevier Inc, Waltham, MA, , 559-572, (2018). https://doi.org/10.1016/B978-0-12-809405-1.00048-1
Kenyon, E., R. Pegram, J. Lipscomb, AND R. Hines. Impact of Scaling Factor Variation on Pharmacokinetic Outcomes in Pediatric Populations: a Case Study Using Bromodichloromethane (BDCM). FutureTox IV, Crystal City, VA, November 14 - 16, 2018.
Lipscomb, J. Risk Assessment Approaches for Acute and Short-Duration Exposures. HS7.53.07. Presented at Toxicology and Risk Assessment Conference, West Chester, Ohio, April 23 - 26, 2018.
Cantwell, M., D. Katz, J. Sullivan, D. Shapley, J. Lipscomb, J. Epstein, A. Juhl, C. Knudson, AND G. O'Mullan. Spatial Patterns of Pharmaceuticals and Wastewater Tracers in the Hudson River Estuary. WATER RESEARCH. Elsevier Science Ltd, New York, NY, 137:335-343, (2018). https://doi.org/10.1016/j.watres.2017.12.044
Lipscomb, J. Standing Operating Procedures (SOP) for the Development of Provisional Advisory Levels (PALs) for Hazardous Chemicals. U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-18/224, 2018.
2017
Juberg, D., T. Knudsen, M. Sander, N. Beck, E. Faustman, D. Mendrick, J. Fowle, T. Hartung, R. Tice, E. Lamazurier, R. Becker, S. Fitzpatrick, G. Daston, A. Harill, R. Hines, D. Keller, J. Lipscomb, D. Watson, T. Bahadori, AND K. Crofton. FutureTox III: Bridges for Translation. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 155(1):22-31, (2017).
Cantwell, M., D. Katz, J. Sullivan, D. Shapley, J. Lipscomb, J. Epstein, A. Juhl, C. Knudson, AND G. O'Mullan. Pharmaceuticals and Wastewater Tracers Along the Lower Hudson River. Coastal and Estuarine Research Federation (CERF) 24th Biennial Conference, Providence, RI, November 05 - 09, 2017.
Kenyon, E., J. Lipscomb, R. Pegram, AND R. Hines. THE IMPACT OF SCALING FACTOR VARIABILITY ON RISK-RELEVANT TOXICOKINETIC OUTCOMES IN CHILDREN: A CASE STUDY USING BROMODICHLOROMETHANE (BDCM). Society of Toxicology, Baltimore, Maryland, March 12 - 16, 2017.
2016
Kenyon, E., C. Eklund, J. Lipscomb, AND R. Pegram. The impact of variation in scaling factors on the estimation of internal dose metrics: a case study using bromodichloromethane (BDCM). Toxicology Mechanisms and Methods. Taylor & Francis, Inc., Philadelphia, PA, 26(8):620-626, (2016).
2015
Meek, B. AND J. Lipscomb. Gaining Acceptance for the use of in vitro Toxicity Assays and QIVIVE in Regulatory Risk Assessment. M Yoon, B Blaaauboer H clewell (ed.), TOXICOLOGY. Elsevier Science Ltd, New York, NY, 332:112-123, (2015).
2012
KENYON, E. M., R. A. PEGRAM, C. R. EKLUND, AND J. C. LIPSCOMB. COMPARISON OF IN VIVO DERIVED AND SCALED IN VITRO METABOLIC RATE CONSTANTS FOR SOME VOLATILE ORGANIC COMPOUNDS (VOCS). Presented at Society of Toxicology (SOT) Annual Meeting, San Francisco, CA, March 11 - 15, 2012.
2010
MAZUR, C. S., J. F. KENNEKE, J. HESS-WILSON, AND J. C. LIPSCOMB. Differences Between Human and Rat Intestinal and Hepatic Bisphenol-A Glucuronidation and the Influence of Alamethicin on In vitro Kinetic Measurements. DRUG METABOLISM AND DISPOSITION. American Society for Pharmacology and Experimental Therapeutics, Bethesda, MD, 38(12):2232-2238, (2010).
2007
MAZUR, C. S., J. F. KENNEKE, C. T. STEVENS, M. S. OKINO, AND J. C. LIPSCOMB. IN VITRO METABOLISM OF THE FUNGICIDE AND ENVIRONMENTAL CONTAMINANT TRANS-BROMUCONAZOLE AND IMPLICATIONS FOR RISK ASSESSMENT. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH - PART A: CURRENT ISSUES. Taylor & Francis, Inc., Philadelphia, PA, 70(14):1241-1250, (2007).
RODRIGUEZ, C. E., D. A. Mahle, J. M. Gearhart, D. R. Mattie, J. C. LIPSCOMB, R. S. Cook, AND H. A. BARTON. Predicting Age-Appropriate Pharmacokinetics of Six Volatile Organic Compounds in the Rat Utilizing Physiologically Based Pharmacokinetic Modeling. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 98(1):43-56, (2007).
2006
OKINO, M. S., M. V. EVANS, FRED W. POWER, W. A. CHIU, J. C. LIPSCOMB, J. N. BLANCATO, AND C. CHEN. EVALUATION OF MULTIPLE PHARMACOKINETIC MODELING STRUCTURES FOR TRICHLOROETHYLENE. Presented at Society of Toxicology, San Diego, CA, March 05 - 09, 2006.
2005
OKINO, M. S., W. CHIU, M. V. EVANS, F. W. POWER, J. C. LIPSCOMB, R. TORNERO-VELEZ, C. C. DARY, J. N. BLANCATO, C. CHEN, AND L. S. BIRNBAUM. SUITABILITY OF USING IN VITRO AND COMPUTATIONALLY ESTIMATED PARAMETERS IN SIMPLIFIED PHARMACOKINETIC MODELS. Presented at North American ISSX Meeting , Maui, HI, October 23 - 27, 2005.
2003
Lipscomb, J. AND G. L. Kedderis. Incorporating Human Interindividual Biotransformation Variance In Health Risk Assessment. The Science of The Total Environment (2002).
Lipscomb, J., L. Teuschler, J. Swartout, C. A. Striley, AND J. E. Snawder. Variance Of Microsomal Protein And Cytochrome P450 2E1 And 3A Forms In Adult Human Liver. (2003).
2002
Snawder, J. E. AND J. Lipscomb. Interindividual Variance Of Cytochrome P450 Forms In Human HEPAtic Microsomes: Correlation Of Individual Forms With Xenobiotic Metabolism And Implications In Risk Assessment. Regulatory Toxicology and Pharmacology 32(2):200-209, (2000).
2001
Kedderis, G. L. AND J. Lipscomb. Application Of In Vitro Biotransformation Data And Pharmacokinetic Modeling To Risk Assessment. TOXICOLOGY AND INDUSTRIAL HEALTH. Princeton Scientific Publishers, Princeton, NJ, 17(5-10): 315-321, (2001).